VAMP3 and atherosclerosis: Notably the in vivo intervention of VAMP3/SNAP23 by systemic delivery of rapamycin ameliorates thrombi formation (Figure 7G), echoing the value of mTOR inhibition in preventing the development of atherosclerosis (Kurdi et al., 2016; Zhu et al., 2017).